<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Major and neglected diseases in developing countries - Thursday, 8 September 2005</title><meta name="title" content="Verbatim report of proceedings - Major and neglected diseases in developing countries - Thursday, 8 September 2005" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2005 - Source: European Parliament" /><meta name="available" content="08-09-2005" /><meta name="sipade-leg" content="6" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Major and neglected diseases in developing countries - Thursday, 8 September 2005" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-6-2005-09-08-ITM-006_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li class="bg" title="bg - български">bg - български</li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li class="hr" title="hr - hrvatski">hr - hrvatski</li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_PT.html">pt - português</a></li>
            <li class="ro" title="ro - română">ro - română</li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-6-2005-09-08-ITM-006_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-6-2005-09-08-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-6-2005-09-08-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-6-2005-09-08-ITM-005_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-6-2005-09-08-ITM-005_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-6-2005-09-08-ITM-007_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-6-2005-09-08-ITM-007_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-6-2005-09-08_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-6-2005-09-08_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table><table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 8 September 2005 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">OJ edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 6. Major and neglected diseases in developing countries</td></tr></table>
<a name="4-051"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28387.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">President. –</span></span>   The next item is the debate on the report (<a href="/doceo/document/A-6-2005-0215_EN.html">A6-0215/2005</a>) by Mr Bowis, on behalf of the Committee on Development, on major and neglected diseases in developing countries [<a href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2005/2047(INI)">2005/2047(INI)</a>]. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-052"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4527.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">John Bowis (PPE-DE), </span></span>  <span class="italic">rapporteur</span>. <span class="bold">–</span> Mr President, my reports always start with a quotation. On this occasion it is: <span class="italic">Principiis obstata; sero medicina paratur cum mala per longas convaluere moras.</span> If that is difficult for the interpreters, that is the oldest language – or one of them – of Europe. It is Ovid, and it translates as 'Stop it at the start; it is late for medicine to be prepared when disease has grown strong through long delays'. That is my theme.</p>
<p class="contents">In 2005, we have seen many health threats, and a new health threat on our agenda as Marburg has emerged in Angola with a mortality rate of over 90%. Europe responded swiftly, supporting <span class="italic">Médecins Sans Frontières, </span>providing not just the powerful antibiotics and the intravenous fluids, but water purification systems and disposable, protective gear.</p>
<p class="contents">That is just one example of the need for vigilance, prevention and rapid response, just one reason why we must never 'cherry-pick' in our battle against disease. We must continue to tackle the big three of AIDS, TB and malaria, but just as many – or even more – people die, become chronically ill or live with disabilities caused by diseases that the world neglects. It is time to end that poverty of fatalism; it is time to bring neglected diseases in from the cold and to bring real hope to those who live with and, too often, die from these diseases.</p>
<p class="contents">Ten per cent of the world's biomedical research funds are dedicated to addressing the problems that are responsible for 90% of the world's burden of disease; that is the imbalance. At the end of 2004, for all neglected diseases, we had just 18 R&amp;D projects in clinical development and a further 42 on the way. While, for other diseases, we had 2 100 projects in clinical development.</p>
<p class="contents">Less than 1% of the 1 393 new drugs placed on the market between 1975 and 1999 were for infectious tropical diseases. Every year, 1.5 million children under five die from vaccine-preventable diseases. Patients suffering from sleeping sickness, leish-maniasis, dengue, trachoma and many others are given, too often, archaic drugs, some highly toxic, some ineffective. Some diseases are neglected because they are rare in western countries, so no market has emerged to develop such drugs. Some are neglected because western drugs are not made available or affordable.</p>
<p class="contents">In my case, I live with diabetes. I have access to western medicine, treatment and care. When we were in Mali for the EU-ACP Joint Parliamentary Assembly, I went to visit the local diabetes support clinics. There were two – only in Bamako – and they could not afford the drugs or the insulin, so the result was amputations and blindness, liver disease and early deaths.</p>
<p class="contents">My call is for more research for neglected diseases and more support for care projects in developing countries.</p>
<p class="contents">Clinical research is slow and patchy. There is plenty of basic research and knowledge about parasites and genomes, but there needs to be more bridging research to translate basic research into tested and safe drugs and clinical applications.</p>
<p class="contents">I support very much the DNDi call for more research in this area, and I hope colleagues will sign up to its campaign. The call is also for more help – both available and affordable – for diseases which affect the developed world, like diabetes, epilepsy, depression and schizophrenia. Fifty-two million people are afflicted with epilepsy in our world; 80% of them are not treated; 70% could live seizure-free lives with comparatively cheap five-euros-a-day anti-epileptic drugs. The story goes on.</p>
<p class="contents">I very much welcome what the Commission has brought forward on HIV/AIDS, malaria and TB. Its communication and then the programme for action are very welcome. We know that there were more new infections with AIDS in 2004 than in any previous year. We know that anti-retroviral prices are an increasingly serious public health hazard – that is a statement by the WHO. We know that malaria is giving real opportunity with the new drugs made from the plant <span class="italic">Artemisia</span>, and we need to accelerate the production and distribution of that as well as of insecticide-protected nets.</p>
<p class="contents">With TB we need to recognise the link to AIDS – the multi-drug resistance versions which kill two million a year. I urge the Commission to carry on its good work on TB, AIDS and malaria and to renew its efforts in the neglected diseases, because they are also killing and debilitating people across the developing world. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-053"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Louis Michel,</span></span>   <span class="italic">Member of the Commission</span>. <span class="bold"></span> <span class="italic">(FR) </span>Mr President, ladies and gentlemen, I would like to congratulate Mr Bowis on his report. He has identified some of the essential points on which the Commission will focus its action over the coming years with the assistance of Parliament and the Member States.</p>
<p class="contents">The European Commission supports the improvement of results in the field of health by means of projects, sectoral budgetary support and general budgetary support relating to results in the field of health. The Commission will also continue to support research and development with a view to preventing, treating and curing diseases, including the so-called neglected diseases. The action programme to speed up the fight against HIV/AIDS, malaria and tuberculosis in external actions, proposes supplementary actions for combating these three major diseases of poverty. The programme proposes a series of coherent and concrete actions that are often jointly managed by the European Commission and the Member States, to be undertaken both in the partner countries and at world level, with a view to strengthening the fight against these diseases and to contribute to achieving the Millennium development objectives.</p>
<p class="contents">Our actions must contribute to increasing the credibility of the policy of prevention, of access for treatment and of investments in the development of new vaccines and other tools and interventions for prevention or treatment. Within this context, Europe will enhance its political dialogue with its partners, with a view to helping them to confront the enormous challenges facing them by means of ambitious strategies and active participation by civil society and the private sector. Europe will contribute to strengthening the capacities of these countries in key fields, in particular regulation in the field of the evaluation and licensing of pharmaceutical products, as well as research.</p>
<p class="contents">I would also like to inform you of other initiatives that I have already taken and which are closely linked to the action programme. The first initiative relates to the human resources crisis in the health sector in the developing countries. As you know, this problem is critical in the countries that are trying to enhance their actions within the framework of the fight against the three diseases. I shall therefore present the College with a communication indicating the means for strengthening this fight, in cooperation with the Member States of the European Union and the African Union.</p>
<p class="contents">I am also going to launch a new initiative aimed at guaranteeing the availability of new medicines. This requires additional support from the World Health Organisation. It will also require new measures at European level, with a view to encouraging – as you have said very well – the private sector to invest in research and development of new medicines more specifically geared towards the curing of diseases suffered by certain countries that are clearly currently of little economic interest to the sector.</p>
<p class="contents">I have tried to give you a clearer idea of how the Commission intends to implement the action programme, through cooperation with the Member States of the European Union, the programming of resources and the launching of specific initiatives. I very much hope to hold a dialogue with you on these issues. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-054"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28261.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alexander Stubb, </span></span>  <span class="italic">on behalf of the PPE-DE Group</span>. <span class="bold">–</span> Mr President, I have always dreamed of being the last speaker before the vote: that is a guarantee for having a lot of people in attendance, although no one really listens.</p>
<p class="contents">I wish to make three very brief points. The first is that my Group and I support Mr Bowis' report, which is excellent. Development policy is often seen as some kind of post-colonial deal that eases our conscience. This time it is not: it is about people and preventing epidemic diseases spreading around the world. These are issues that touch all of us and my Group therefore supports it.</p>
<p class="contents">My second observation is that this field needs more research. We know very little about epidemic diseases and how they spread. Extensive work is being done, but more money needs to be invested and the Commission, and indeed the European Union, could be the right source.</p>
<p class="contents">My final point is that we need more money. It is absolutely clear, as also pointed out in Mr Bowis' report, that funding is the main priority. For example, between the years 1975 and 1999, less than 1% of new medicines was for the treatment of tropical and epidemic diseases. We really need to do some work. What we basically need is more money and research, but my Group fully supports the report on the table. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-055"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="italic">(At this point the debate was suspended for voting time)</span> </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-056"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents" align="center"><span class="bold">IN THE CHAIR: MR COCILOVO</span><br /><span class="italic">Vice-President</span></p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
